Cargando…

Portable coagulometer for vitamin K-antagonist monitoring: the patients’ point of view

PURPOSE: The aim of this study was to know the patients’ point of view on the monitoring of vitamin K-antagonist (VKA) therapy by means of a point of care testing (POCT), ie, using a portable coagulometer by self-testing at home. At first, patients had prothrombin time (PT) international normalized...

Descripción completa

Detalles Bibliográficos
Autores principales: Barcellona, Doris, Mastino, Diego, Marongiu, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112808/
https://www.ncbi.nlm.nih.gov/pubmed/30197503
http://dx.doi.org/10.2147/PPA.S164680
_version_ 1783350908771368960
author Barcellona, Doris
Mastino, Diego
Marongiu, Francesco
author_facet Barcellona, Doris
Mastino, Diego
Marongiu, Francesco
author_sort Barcellona, Doris
collection PubMed
description PURPOSE: The aim of this study was to know the patients’ point of view on the monitoring of vitamin K-antagonist (VKA) therapy by means of a point of care testing (POCT), ie, using a portable coagulometer by self-testing at home. At first, patients had prothrombin time (PT) international normalized ratio (INR) monitoring at a thrombosis center; afterward, they were shifted to self-testing at home. An interview was done to evaluate the patients’ point of view on the two monitoring periods. PATIENTS AND METHODS: A total of 92 oral anticoagulated patients were enrolled. The questionnaire contained nine questions that elicited a maximum of five closer answers that were arranged in increasing levels of satisfaction: very little, little, enough, much and completely. Percentage of time in therapeutic range (TTR) and adverse events were compared during the two periods of conventional monitoring and self-testing. RESULTS: The period of conventional monitoring was shorter than that of self-testing (p<0.0001), and the median TTR was satisfactory but lower than that of self-testing (p<0.0001). A total of 85% of the patients were satisfied with self-testing at home. In all, 83% and 73% (p=0.06) of patients felt comfortable about side effects while measuring the PT INR at both home and the thrombosis center, respectively. During the self-testing period, quality of life was improved in 87% of the patients. The cost of test strips was medium–high for 89% of the patients, and 75% of them stated that it was worth improving their quality of life. A switch from VKA to a direct oral anticoagulant (DOAC) was proposed to 24% of the patients, but 68% of them declined because they felt more comfortable monitoring their oral anticoagulant therapy by POCT. CONCLUSION: VKA monitoring using POCT at home may play a role in improving the patients’ quality of life and may be considered as an alternative to the use of DOAC at least in certain settings of patients.
format Online
Article
Text
id pubmed-6112808
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61128082018-09-07 Portable coagulometer for vitamin K-antagonist monitoring: the patients’ point of view Barcellona, Doris Mastino, Diego Marongiu, Francesco Patient Prefer Adherence Original Research PURPOSE: The aim of this study was to know the patients’ point of view on the monitoring of vitamin K-antagonist (VKA) therapy by means of a point of care testing (POCT), ie, using a portable coagulometer by self-testing at home. At first, patients had prothrombin time (PT) international normalized ratio (INR) monitoring at a thrombosis center; afterward, they were shifted to self-testing at home. An interview was done to evaluate the patients’ point of view on the two monitoring periods. PATIENTS AND METHODS: A total of 92 oral anticoagulated patients were enrolled. The questionnaire contained nine questions that elicited a maximum of five closer answers that were arranged in increasing levels of satisfaction: very little, little, enough, much and completely. Percentage of time in therapeutic range (TTR) and adverse events were compared during the two periods of conventional monitoring and self-testing. RESULTS: The period of conventional monitoring was shorter than that of self-testing (p<0.0001), and the median TTR was satisfactory but lower than that of self-testing (p<0.0001). A total of 85% of the patients were satisfied with self-testing at home. In all, 83% and 73% (p=0.06) of patients felt comfortable about side effects while measuring the PT INR at both home and the thrombosis center, respectively. During the self-testing period, quality of life was improved in 87% of the patients. The cost of test strips was medium–high for 89% of the patients, and 75% of them stated that it was worth improving their quality of life. A switch from VKA to a direct oral anticoagulant (DOAC) was proposed to 24% of the patients, but 68% of them declined because they felt more comfortable monitoring their oral anticoagulant therapy by POCT. CONCLUSION: VKA monitoring using POCT at home may play a role in improving the patients’ quality of life and may be considered as an alternative to the use of DOAC at least in certain settings of patients. Dove Medical Press 2018-08-22 /pmc/articles/PMC6112808/ /pubmed/30197503 http://dx.doi.org/10.2147/PPA.S164680 Text en © 2018 Barcellona et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Barcellona, Doris
Mastino, Diego
Marongiu, Francesco
Portable coagulometer for vitamin K-antagonist monitoring: the patients’ point of view
title Portable coagulometer for vitamin K-antagonist monitoring: the patients’ point of view
title_full Portable coagulometer for vitamin K-antagonist monitoring: the patients’ point of view
title_fullStr Portable coagulometer for vitamin K-antagonist monitoring: the patients’ point of view
title_full_unstemmed Portable coagulometer for vitamin K-antagonist monitoring: the patients’ point of view
title_short Portable coagulometer for vitamin K-antagonist monitoring: the patients’ point of view
title_sort portable coagulometer for vitamin k-antagonist monitoring: the patients’ point of view
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112808/
https://www.ncbi.nlm.nih.gov/pubmed/30197503
http://dx.doi.org/10.2147/PPA.S164680
work_keys_str_mv AT barcellonadoris portablecoagulometerforvitaminkantagonistmonitoringthepatientspointofview
AT mastinodiego portablecoagulometerforvitaminkantagonistmonitoringthepatientspointofview
AT marongiufrancesco portablecoagulometerforvitaminkantagonistmonitoringthepatientspointofview